Therapeutic Effect of Anti-VEGF for Age-Related Macular Degeneration in the Untreated Fellow Eye

Intravitreal injections of antivascular endothelial growth factor (anti-VEGF) agents have been reported to occasionally produce a therapeutic effect in the uninjected fellow eye. Here, three patients with bilateral neovascular age-related macular degeneration are presented. In all three patients, un...

Descripción completa

Detalles Bibliográficos
Autores principales: Isildak, Hacer, Schwartz, Stephen G., Flynn, Harry W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941819/
https://www.ncbi.nlm.nih.gov/pubmed/29850326
http://dx.doi.org/10.1155/2018/8561895
_version_ 1783321363169148928
author Isildak, Hacer
Schwartz, Stephen G.
Flynn, Harry W.
author_facet Isildak, Hacer
Schwartz, Stephen G.
Flynn, Harry W.
author_sort Isildak, Hacer
collection PubMed
description Intravitreal injections of antivascular endothelial growth factor (anti-VEGF) agents have been reported to occasionally produce a therapeutic effect in the uninjected fellow eye. Here, three patients with bilateral neovascular age-related macular degeneration are presented. In all three patients, unilateral anti-VEGF injection resulted in bilateral reduction of macular thickness as measured by spectral domain optical coherence tomography.
format Online
Article
Text
id pubmed-5941819
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-59418192018-05-30 Therapeutic Effect of Anti-VEGF for Age-Related Macular Degeneration in the Untreated Fellow Eye Isildak, Hacer Schwartz, Stephen G. Flynn, Harry W. Case Rep Ophthalmol Med Case Report Intravitreal injections of antivascular endothelial growth factor (anti-VEGF) agents have been reported to occasionally produce a therapeutic effect in the uninjected fellow eye. Here, three patients with bilateral neovascular age-related macular degeneration are presented. In all three patients, unilateral anti-VEGF injection resulted in bilateral reduction of macular thickness as measured by spectral domain optical coherence tomography. Hindawi 2018-04-24 /pmc/articles/PMC5941819/ /pubmed/29850326 http://dx.doi.org/10.1155/2018/8561895 Text en Copyright © 2018 Hacer Isildak et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Isildak, Hacer
Schwartz, Stephen G.
Flynn, Harry W.
Therapeutic Effect of Anti-VEGF for Age-Related Macular Degeneration in the Untreated Fellow Eye
title Therapeutic Effect of Anti-VEGF for Age-Related Macular Degeneration in the Untreated Fellow Eye
title_full Therapeutic Effect of Anti-VEGF for Age-Related Macular Degeneration in the Untreated Fellow Eye
title_fullStr Therapeutic Effect of Anti-VEGF for Age-Related Macular Degeneration in the Untreated Fellow Eye
title_full_unstemmed Therapeutic Effect of Anti-VEGF for Age-Related Macular Degeneration in the Untreated Fellow Eye
title_short Therapeutic Effect of Anti-VEGF for Age-Related Macular Degeneration in the Untreated Fellow Eye
title_sort therapeutic effect of anti-vegf for age-related macular degeneration in the untreated fellow eye
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941819/
https://www.ncbi.nlm.nih.gov/pubmed/29850326
http://dx.doi.org/10.1155/2018/8561895
work_keys_str_mv AT isildakhacer therapeuticeffectofantivegfforagerelatedmaculardegenerationintheuntreatedfelloweye
AT schwartzstepheng therapeuticeffectofantivegfforagerelatedmaculardegenerationintheuntreatedfelloweye
AT flynnharryw therapeuticeffectofantivegfforagerelatedmaculardegenerationintheuntreatedfelloweye

Ejemplares similares